QS-21 Stimulon
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QS-21 Stimulon, covering 2024-09-23 to 2024-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer [Phase 2]